S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:50 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

CVM

CEL SCI CORP
NYSE · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
1.63
+0.02 +1.24%
USD · close Sep 4

One year, everything drawn on

251 SESSIONS · DAILY CLOSES
117.713.950.19Aug 25 · Chief Executive Officer buy $138KAug 14 · 10-Q filed (Q3 2026)Aug 14 · 10-Q filed (Q2 2026)Aug 14 · 10-Q filed (Q1 2026)Dec 29 · 10-K filed (FY 2025)Dec 29 · 10-K filed (Q4 2025)Aug 14 · 10-Q filed (Q3 2025)Aug 14 · 10-Q filed (Q2 2025)Aug 14 · 10-Q filed (Q1 2025)Dec 29 · 10-K filed (FY 2024)Dec 29 · 10-K filed (Q4 2024)SEP 2025OCTJAN 2026APRJUL
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-09-06
Insiders (90d): $138K net buying · 1 distinct buyer
Shorts (latest report): 714K short · −486K last period
Every line of the math
81PASS

Congress is trading it

No STOCK Act disclosure names CVM.

Insider activity

ALL 1
DateInsiderTypeValue
Aug 25Chief Executive OfficerBuy$138K
Watch CVM. Know when insiders buy.
One email the day a filing lands. Free.